Tan Lixin, Song An, Ren Luping, Wang Chao, Song Guangyao
Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China.
Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100191, PR China.
Saudi J Biol Sci. 2020 May;27(5):1317-1323. doi: 10.1016/j.sjbs.2020.03.014. Epub 2020 Mar 18.
To study the changes of lipid deposition in skeletal muscle of insulin resistance rat and the effect of pioglitazone intervention on the expression of AMPK pathway related genes in rat, a rat model of insulin resistance was induced and constructed by high fructose diet as an test group, and normal rats were used as a control group. First, the effect of pioglitazone intervention on serum lipids-related indicators and mRNA expression levels of fat-related genes in skeletal muscle in rats was investigated. Then skeletal muscle sections were made and stained with oil red O to investigate the effect of pioglitazone intervention on lipid deposition in skeletal muscle of rats. Finally, the effects of pioglitazone intervention therapy on the mRNA and protein expression of related genes in the AMPK signaling pathway in skeletal muscle tissue of rat were explored by real-time quantitative PCR (qRT-PCR) and Western-blotting technology. The results showed that the blood glucose (BG), insulin (INS), adiponectin (ADPN), free fatty acid (FFA), triglyceride (TG), and cholesterol (TC) levels in serum of the test group were higher than the control group ( < 0.05); the visceral fat weight and abdominal fat index of the test group were significantly higher than the control group ( < 0.01); after the pioglitazone intervention, all blood lipid-related indexes in the rat model were significantly lower than before the intervention ( < 0.05); skeletal muscle section staining results showed that the number of lipid droplets in skeletal muscle of rat model was significantly reduced after pioglitazone intervention; and pioglitazone intervention can significantly increase the mRNA and protein expression levels of p-ACC, GLUT7, PGC-1α, and CPT1 genes in the skeletal muscles of experimental rats ( < 0.05). Accordingly, it can be concluded that pioglitazone can play a role in treating insulin resistance by regulating the expression of related genes of AMPK, ACC, etc. in the AMPK signaling pathway.
为研究胰岛素抵抗大鼠骨骼肌脂质沉积变化及吡格列酮干预对大鼠AMPK通路蛋白激酶A(AMPK)信号通路相关基因表达的影响,采用高糖饮食诱导并构建胰岛素抵抗大鼠模型作为试验组,以正常大鼠作为对照组。首先,研究吡格列酮干预对大鼠血清脂质相关指标及骨骼肌脂肪相关基因mRNA表达水平的影响。然后制作骨骼肌切片并用油红O染色,以研究吡格列酮干预对大鼠骨骼肌脂质沉积的影响。最后,通过实时定量聚合酶链反应(qRT-PCR)和蛋白质免疫印迹技术,探讨吡格列酮干预治疗对大鼠骨骼肌组织AMPK信号通路相关基因mRNA和蛋白表达的影响。结果显示,试验组大鼠血清中的血糖(BG)、胰岛素(INS)、脂联素(ADPN)、游离脂肪酸(FFA)、甘油三酯(TG)和胆固醇(TC)水平高于对照组(P<0.05);试验组大鼠的内脏脂肪重量和腹脂指数显著高于对照组(P<0.01);吡格列酮干预后,大鼠模型的各项血脂相关指标均显著低于干预前(P<0.05);骨骼肌切片染色结果显示,吡格列酮干预后大鼠模型骨骼肌中脂滴数量显著减少;吡格列酮干预可显著提高试验大鼠骨骼肌中p-ACC、葡萄糖转运蛋白7(GLUT7)、过氧化物酶体增殖物激活受体γ共激活因子1α(PGC-1α)和肉碱/有机阳离子转运体1(CPT1)基因的mRNA和蛋白表达水平(P<0.05)。据此得出结论,吡格列酮可通过调节AMPK信号通路中AMPK、乙酰辅酶A羧化酶(ACC)等相关基因的表达发挥治疗胰岛素抵抗的作用。